Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISAP: Inhaled Glucocorticoids for Acute Pharyngitis
NCT04027322Phase 3Completed
- Sponsor
- Oman Medical Specialty Board
- Start
- Jun 2019
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide and dexamethasone in acute pharyngitis (3 arms), sponsored by Oman Medical Specialty Board. Primary endpoint: Number of participants with the complete resolution of sore throat at 24 hours. Started Jun 2019; status: completed.
02
Drugs
budesonidedexamethasone
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on NCT04027322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04027322.